Gene Therapy Approaches to Parkinson's Disease: Preclinical to Clinical Trials, or What Steps to Take to Get There from Here?

Author： Redmond D.E.  

Publisher： Elsevier

ISSN： 0014-4886

Source： Experimental Neurology, Vol.144, Iss.1, 1997-03, pp. : 160-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

From Transplants to Gene Therapy for Parkinson's Disease

By Freeman T.B.  

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 47-50

Elsevier

Access to resources Recommend Favorite

l-Dopa and Dopamine-Producing Gene Cassettes for Gene Therapy Approaches to Parkinson's Disease

By Moffat M.   Harmon S.   Haycock J.   O'Malley K.L.  

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 69-73

Elsevier

Access to resources Recommend Favorite

How to Get from Here to There: Macrophage Recruitment in Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 8, Iss. 2, 2011-03 ,pp. : 156-163

Bentham Science Publishers

Access to resources Recommend Favorite

GDNF treatment in Parkinson’s disease: time for controlled clinical trials?

By Brundin Patrik  

Brain, Vol. 125, Iss. 10, 2002-10 ,pp. : 2149-2151

Oxford University Press

Access to resources Recommend Favorite

Application ofex VivoGene Therapy in the Treatment of Parkinson's Disease

By Raymon H.K.   Thode S.   Gage F.H.  

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 82-91

Elsevier

Access to resources Recommend Favorite